©The Author(s) 2026.
World J Diabetes. Feb 15, 2026; 17(2): 111453
Published online Feb 15, 2026. doi: 10.4239/wjd.v17.i2.111453
Published online Feb 15, 2026. doi: 10.4239/wjd.v17.i2.111453
Figure 5 Jiangtang Tiaozhi formula modulates liver metabolite profiles.
A: Volcano plots under the positive ion mode (model vs control mice, n = 8); B: Volcano plots under the ion mode (model vs control mice, n = 8); C: Volcano plots under the positive ion mode [Jiangtang Tiaozhi formula (JTTZF) vs model mice, n = 8]; D: Volcano plots under the negative ion mode (JTTZF vs model mice, n = 8); E: Overview of metabolic pathway analysis of liver metabolism (model vs control mice, n = 8); F: Overview of metabolic pathway analysis of liver metabolism (JTTZF vs model mice, n = 8). J: Jiangtang Tiaozhi formula group; Mo: Model group; C: Control group; VIP: Variable important in projection; TCA: Tricarboxylic acid cycle.
- Citation: Tian JX, Zhang YJ, Zhang YX, Wei JH, Fang XY, Miao RY, Ma KL, Guan HF, Wang XM, Wu HR. Integrated hepatic transcriptome and metabolome reveal the mechanisms of Jiangtang Tiaozhi formula on improving glycolipid metabolic disorder. World J Diabetes 2026; 17(2): 111453
- URL: https://www.wjgnet.com/1948-9358/full/v17/i2/111453.htm
- DOI: https://dx.doi.org/10.4239/wjd.v17.i2.111453